These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 1851645)
21. [Hepatitis markers in hemodialysis patients]. Leblebicioğlu H; Günaydin M; Cengiz K; Işlek I Mikrobiyol Bul; 1993 Oct; 27(4):321-6. PubMed ID: 7505387 [TBL] [Abstract][Full Text] [Related]
22. Hepatitis C and hepatitis B virus infection in hemodialysis patients and staff: a two year follow-up. Jankovic N; Cala S; Nadinić B; Varlaj-Knobloch V; Pavlović D Int J Artif Organs; 1994 Mar; 17(3):137-40. PubMed ID: 7519583 [TBL] [Abstract][Full Text] [Related]
23. Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden. Mattsson L; Grillner L; von Sydow M; Bergdahl S; Weiland O Infection; 1991; 19(5):309-12. PubMed ID: 1666063 [TBL] [Abstract][Full Text] [Related]
24. Antibodies against hepatitis C virus in hemodialysis patients in the central Italian region of Umbria: evaluation of some risk factors. Brugnano R; Francisci D; Quintaliani G; Gaburri M; Nori G; Verdura C; Giombini L; Buoncristiani U Nephron; 1992; 61(3):263-5. PubMed ID: 1323768 [TBL] [Abstract][Full Text] [Related]
25. HCV incidence in a dialysis center: preliminary reports. Ippolito E; Aterini S; Salvadori M; D'Elia G; Amato M Nephron; 1992; 61(3):375-6. PubMed ID: 1323797 [TBL] [Abstract][Full Text] [Related]
26. Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver disease. Fabrizi F; Marcelli D; Bacchini G; Guarnori I; Erba G; Locatelli F Nephrol Dial Transplant; 1994; 9(7):780-4. PubMed ID: 7526275 [TBL] [Abstract][Full Text] [Related]
27. Detection of antibodies to HCV in haemodialysis patients using two second generation ELISA tests. Dentico P; Volpe A; Buongiorno R; Fiore G; Carbone M; Manno C; Pastore G; Schiraldi O Ital J Gastroenterol; 1993 Jan; 25(1):19-22. PubMed ID: 7679012 [TBL] [Abstract][Full Text] [Related]
28. [A study on the patterns of early specific antibody response in patients with posttransfusion hepatitis C]. Hao F; Li MD Zhonghua Nei Ke Za Zhi; 1994 Sep; 33(9):593-6. PubMed ID: 7536148 [TBL] [Abstract][Full Text] [Related]
29. Antibodies against hepatitis C virus (anti-HCV) in haemodialysis patients: association with hepatitis B serological markers. Elisaf M; Tsianos E; Mavridis A; Dardamanis M; Pappas M; Siamopoulos KC Nephrol Dial Transplant; 1991; 6(7):476-9. PubMed ID: 1717891 [TBL] [Abstract][Full Text] [Related]
31. Prevalence of hepatitis C virus infection among long-term hemodialysis patients: detection of hepatitis C virus RNA in plasma. Sakamoto N; Enomoto N; Marumo F; Sato C J Med Virol; 1993 Jan; 39(1):11-5. PubMed ID: 7678636 [TBL] [Abstract][Full Text] [Related]
32. Prevalence of antibody to hepatitis C virus in hemodialysis patients. Hayashi J; Nakashima K; Kajiyama W; Noguchi A; Morofuji M; Maeda Y; Kashiwagi S Am J Epidemiol; 1991 Sep; 134(6):651-7. PubMed ID: 1659184 [TBL] [Abstract][Full Text] [Related]
33. Seropositivity to hepatitis C virus in Tunisian haemodialysis patients. Jemni S; Ikbel K; Kortas M; Mahjoub J; Ghachem L; Bidet JM; Boukef K Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):349-51. PubMed ID: 7534398 [TBL] [Abstract][Full Text] [Related]
34. High prevalence of antibodies to hepatitis C virus in three haemodialysis centres in south-western Poland. Hruby Z; Sliwiński J; Molin I; Zalewska M; Knysz B; Czyz W; Steciwko A; Bogucki J; Gładysz A Nephrol Dial Transplant; 1993; 8(8):740-3. PubMed ID: 7692355 [TBL] [Abstract][Full Text] [Related]
35. Detection of antibodies to hepatitis C virus in dialysis patients. Rivanera D; Lilli D; Lorino G; Pirozzi V; Cannulla V; Dicuonzo G; Mancini C Eur J Epidemiol; 1993 Jan; 9(1):55-8. PubMed ID: 7682515 [TBL] [Abstract][Full Text] [Related]
36. HCV and HBV infection among multitransfused thalassemics from eastern Sicily. Cacopardo B; Russo R; Fatuzzo F; Cosentino S; Lombardo T; La Rosa R; Celesia BM; Nigro L; Frontini V; Nunnari A Infection; 1992; 20(2):83-5. PubMed ID: 1374737 [TBL] [Abstract][Full Text] [Related]
37. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients]. Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725 [TBL] [Abstract][Full Text] [Related]
38. [The prevalence of serum anti-hepatitis C virus antibodies in hemodialyzed patients]. Motta M; Brischetto R; Rapisarda F; Corno C; Rapisarda C; Fatuzzo P; Messina A; Biondi A; Mezzasalma E; Calcara G Ann Ital Med Int; 1991; 6(4):375-8. PubMed ID: 1666516 [TBL] [Abstract][Full Text] [Related]
39. A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group. Pereira BJ; Wright TL; Schmid CH; Levey AS Lancet; 1995 Feb; 345(8948):484-7. PubMed ID: 7532254 [TBL] [Abstract][Full Text] [Related]
40. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Esteban JI; López-Talavera JC; Genescà J; Madoz P; Viladomiu L; Muñiz E; Martin-Vega C; Rosell M; Allende H; Vidal X Ann Intern Med; 1991 Sep; 115(6):443-9. PubMed ID: 1651674 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]